An injectable SERS based plasmonic biosensor to monitor patients with cancer

This poster, presented at the SelectScience^® Virtual Analytical Science Summit 2022, proposes the development of a remote nanobiosensor for high-risk profile cancer patients, to be injected into the dermis layer of the skin. Biomolecules in the interstitial fluid (ISF) will diffuse through the sensor and subsequently be detected by surface-enhanced Raman scattering (SERS) spectroscopy to obtain the fingerprint of the cancer biomarkers.